Zacks Investment Research upgraded EndoChoice from a “hold” rating to a “buy” rating.
SpectraScience acquired the assets of Oncoscope.
Mauna Kea Technologies enrolled more than 200 patients in its CONTACT II clinical study.
Miraca Life Sciences launched the EoGenius test, which helps diagnose and monitor patients with eosinophilic esophagitis.
More articles on GI/endoscopy:
GI physician leader to know: Dr. Neena Abraham of Mayo Clinic
5 most read GI/endoscopy stories: Week of Feb. 29 – March 4
St. Francis Regional, Ridgeview medical centers come together for GI care: 4 things to know
